About Contact Us Careers

Anti-Asthma TDM Assay Kits Market Size and Forecast, by Product Type (ELISA Assay Kits, Immunoassay Kits), Assay Type (Anti-Asthma, Bronchodilator), End-user (Hospitals, Diagnostic Laboratories, Research Centers & Academic Institutes) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4143
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT

Anti-Asthma TDM Assay Kits Market Outlook:

Anti-Asthma TDM Assay Kits Market size was valued at USD 22.11 billion in 2025 and is expected to reach USD 39.22 billion by 2035, expanding at around 5.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of anti-asthma TDM assay kits is evaluated at USD 23.28 billion.

anti-asthma-TDM-assay-kits-market
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the escalating cases of asthma worldwide. TDM is used to measure the plasma concentration of the drug in the given therapy, and it involves measuring drug concentration and clinical interpretation of the result. Asthma is thought to affect at least 300 million individuals worldwide, 30 million of whom reside in mainland China.

In addition to these, factors that are believed to fuel the market growth of anti-asthma TDM assay kits include the rise in the consumption of tobacco. Scientists claim that tobacco smoke is a common trigger for asthma. The smoke from tobacco products, such as cigars, cigarettes, or pipes can aggravate the condition. The data released by the World Health Organization states that in 2020, 22.3% of the world population used tobacco. On account of excessively increasing tobacco users, the global anti-asthma TDM assay kits market is estimated to grow during the forecast period. Also, the worsening air quality is causing various respiratory diseases and asthma is the most common of all. This is also estimated to fuel the global anti-asthma TDM assay kits market growth during the forecast period. The World Health Organization (WHO) estimates that, as of 2019, 99% of the world's population resided in areas where the WHO's air quality standards were not being met. According to data from the same year, more than 90% of individuals worldwide lived in regions where PM2.5 concentrations were higher than the WHO annual air quality criteria (AQG), which are 10 g/m3.

Key Anti-Asthma TDM Assay Kits Market Insights Summary:

  • Regional Highlights:

    • North America is expected to command the largest share by 2035 in the anti-asthma TDM assay kits market, owing to the rising prevalence of asthma across the region.

  • Segment Insights:

    • The ELISA assay kits segment in the anti-asthma TDM assay kits market is projected to secure the largest share by 2035, propelled by the growing availability and variants of ELISA test kits.

  • Key Growth Trends:

    • Increasing Consumption of Tobacco
    • Rising Cases of Asthma

  • Major Challenges:

    • Shortage of skilled workers who can perform the test efficiently
    • Lack of medical reimbursement policies for asthma patient

  • Key Players: F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Svar Life Science AB, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, Elabscience Biotechnology Inc., MyBioSource Inc., Creative Diagnostics, Diagnostic Automation (Cortez Diagnostics, Inc.).

Global Anti-Asthma TDM Assay Kits Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 22.11 billion
    • 2026 Market Size: USD 23.28 billion
    • Projected Market Size: USD 39.22 billion by 2035
    • Growth Forecasts: 5.9%

  • Key Regional Dynamics:

    • Largest Region: North America (Largest Share by 2035)
    • Fastest Growing Region: North America
    • Dominating Countries: United States, China, Germany, Japan, United Kingdom
    • Emerging Countries: India, Brazil, South Korea, Mexico, Indonesia

    • Last updated on : 21 November, 2025

Growth Drivers

  • Increasing Consumption of Tobacco – Smoke affects the airways, which results in the same symptoms that occur during an asthma attack: swelling, narrowing, and the buildup of sticky mucus. Moreover, even if a person does not smoke, asthma can occur owing to secondhand smoke or passive smoking. Moreover, the pollutants from tobacco in the air can lead to acute sinusitis, which requires acute sinusitis treatment at an earlier stage, and it is anticipated to boost the market’s growth. According to the World Health Organization, around 1.2 million of those fatalities are caused by non-smokers being exposed to secondhand smoke, while more than 7 million are caused by direct tobacco use. Moreover, each year, more than 8 million people are killed by tobacco.
  • Rising Cases of Asthma – Growing cases of asthma are expected to boost the demand for anti-asthma TDM assay kits. In the US, 25 million people suffer from asthma. This equates to about 1 in every 13 people. Over 20 million Americans age 18 and over suffer from asthma.
  • Increasing Concentration of Pollutants in the Air– As per the data of the Environmental Protection Agency, between the years 1990-2020, the level of concentration of carbon monoxide and nitrogen increased by 73% and 61%, respectively. Moreover, the emission of sulfur dioxide increased by 91%, and the concentration of ozone and coarse particulate matter leveled up by 25% and 26%, respectively.
  • Growing Demand for Medical Precaution for Asthma – Diagnostic test can help the patient to know the severity of the issue and asthma & COPD drugs can help to even prevent it. Over the previous four years, sales of anti-asthma medications have increased by over 50% throughout the nation.
  • Rising Investment in Medicines for Asthma– The British pharmaceutical, AstraZeneca is investing about USD 77 million to increase respiratory drug production at its Sydney facility. This facility is expected to fulfill the rising demand in China for anti-asthmatic drugs.

Challenges

  • Shortage of skilled workers who can perform the test efficiently- The increasing cases of asthma in the world is growing the demand for anti-asthma TDM assay kits. These tests are best performed by the skilled worker, to acquire a result with precision. Therefore, a dearth of skilled workers is expected to hamper the market growth.
  • Lack of medical reimbursement policies for asthma patient
  • Lack of Awareness about anti-asthma test kits

Anti-Asthma TDM Assay Kits Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

5.9%

Base Year Market Size (2025)

USD 22.11 billion

Forecast Year Market Size (2035)

USD 39.22 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Anti-Asthma TDM Assay Kits Market Segmentation:

The global anti-asthma TDM assay kits market is segmented and analyzed for demand and supply by product type into ELISA assay kits, immunoassay kits, and others. Out of the three types of products, the ELISA assay kits segment is estimated to gain the largest market share over the projected time frame. The enzyme-linked immunosorbent assay, or ELISA test, quantifies the quantity of allergen-specific antibodies in our body. The growth of the segment can be attributed to the rise in the number of variants of ELISA test kits manufactured in the market. For instance, a leading manufacturer of China, Wuhan Fine Biotech Co., Ltd. currently have more than 7600 types of ELISA kits in the market.

The global anti-asthma TDM assay kits market is also segmented and analyzed for demand and supply by end-user in hospitals, diagnostic laboratories, research centers & academic institutes. Amongst these three segments, the hospital segment is expected to garner a significant share. Patients suffering from asthma often visit hospitals for treatment, and Acute asthma attacks continue to be a common reason for ER visits and hospital admissions. In 2018, around 6 million asthma patients visited hospitals for treatment. Moreover, in the same year, around 180,000 people were discharged from hospital inpatient care and nearly 2 million asthmatic patients were released from the hospital's emergency department. Furthermore, asthma-related visits to the emergency room are approximately five times as common among black Americans than among white Americans.

Our in-depth analysis of the global anti-asthma TDM assay kits market includes the following segments:

         By Product Type
  • ELISA Assay Kits
  • Immunoassay Kits
  • Others

            By Assay Type
  • Anti-Asthma
  • Bronchodilator

            By End User
  • Hospitals
  • Diagnostic Laboratories
  • Research Centers & Academic Institutes
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Anti-Asthma TDM Assay Kits Market - Regional Analysis

North America Market Insights

North America industry is set to hold largest revenue share by 2035.The growth of the market can be attributed majorly to the increasing count of patients suffering from asthma. A recent report published by the Asthma and Allergy Foundation of America states that approximately 25 million people living in the United States have asthma. On the other hand, the deteriorating quality of air in the region is expected to boost the market growth in the region. Research by the American Lung Association found that more than 135 million Americans breathe toxic air, putting their health and lives in danger.

anti-asthma-TDM-assay-kits-market-size
Get Strategic Analysis by Region Now: Request Free Sample PDF

Anti-Asthma TDM Assay Kits Market Players:

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio-Techne Corporation
    • Svar Life Science AB
    • Thermo Fisher Scientific Inc.
    • Eagle Biosciences, Inc.
    • Merck KGaA
    • Elabscience Biotechnology Inc.
    • MyBioSource Inc.
    • Creative Diagnostics
    • Diagnostic Automation (Cortez Diagnostics, Inc.)

Recent Developments

  • Thermo Fisher Scientific joins hands with TransMIT GmbH on an Orbitrap Mass Spectrometry Imaging Platform.

  • Carterra and Bio-Techne, a leading supplier of innovative and high-quality tools for life science research, collaborated on clinical research for the COVID-19 variant analysis.

  • Report ID: 4143
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of anti-asthma TDM assay kits is evaluated at USD 23.28 billion.

The global anti-asthma TDM assay kits market size exceeded USD 22.11 billion in 2025 and is set to expand at a CAGR of over 5.9%, surpassing USD 39.22 billion revenue by 2035.

North America is expected to command the largest share by 2035 in the anti-asthma TDM assay kits market, owing to the rising prevalence of asthma across the region.

Key players in the market include F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Svar Life Science AB, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, Elabscience Biotechnology Inc., MyBioSource Inc., Creative Diagnostics, Diagnostic Automation (Cortez Diagnostics, Inc.).

Anti-Asthma TDM Assay Kits Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos